GPCR - Structure Therapeutics Inc.
63.13
0.095 0.150%
Share volume: 624,070
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$63.04
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-13-2024 | 02-27-2025 | 05-08-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 32.015 M | 33.316 M | 45.836 M | 47.061 M | 56.311 M | 73.787 M | 86.260 M | |
| Selling general and admin | 11.336 M | 11.266 M | 13.238 M | 13.574 M | 13.444 M | 14.798 M | 17.571 M | |
| Research and development | 20.679 M | 22.050 M | 32.598 M | 33.487 M | 42.867 M | 58.989 M | 68.689 M | |
| Total expenses | 32.015 M | 33.316 M | 45.836 M | 47.061 M | 56.311 M | 73.787 M | -23.989 M | |
| 4.06% | 37.58% | 2.67% | 19.66% | 31.03% | -132.51% | |||
| Operating income | -32.015 M | -33.316 M | -45.836 M | -47.061 M | -56.311 M | -73.787 M | 23.989 M | |
| Ebit | -32.015 M | -33.316 M | -45.836 M | -47.061 M | -56.311 M | -73.787 M | 23.989 M | |
| Pretax income | -26.007 M | -25.981 M | -33.885 M | -36.343 M | -46.735 M | -65.604 M | 33.174 M | |
| -0.10% | 30.42% | 7.25% | 28.59% | 40.37% | -150.57% | |||
| Income tax | 29.000 K | 53.000 K | 92.000 K | 136.000 K | 98.000 K | 108.000 K | 170.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -26.036 M | -26.034 M | -33.977 M | -36.479 M | -46.833 M | -65.712 M | 33.004 M | |
| 0.01% | -30.51% | -7.36% | -28.38% | -40.31% | 150.23% |